Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Dimitrios Karussis, MD, PhD
Repeated Intrathecal Injection of NeuroGenesis’ Mesenchymal Stem Cell Therapy Reveals Potential Benefit in Progressive MS

March 16th 2024

A recent analysis of a phase 2 trial showed that repeated intrathecal injections of MSC therapy led to significant reductions in serum biomarkers and improvements in neurological function for progressive MS.

FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis
FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis

March 11th 2024

Barry A. Singer, MD
Switching From Anti-CD20 Therapy to Ublituximab Shows Promising Results in Phase 3b ENHANCE Trial

March 7th 2024

Carl Marci, MD, chief clinical officer and chief psychiatrist and managing director of Mental Health and Neuroscience at OM1
Machine Learning Model Enhances Real-World Studies for Predicting Disability Progression in Multiple Sclerosis

March 7th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.